Search Results

There are 17052 results for: content related to: In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene

  1. Achievements, challenges and unmet needs for haemophilia patients with inhibitors

    Haemophilia

    Volume 22, Issue S1, January 2016, Pages: 1–24, Y. Dargaud, A. Pavlova, S. Lacroix-Desmazes, K. Fischer, M. Soucie, S. Claeyssens, D.w. Scott, R. d'Oiron, G. Lavigne-Lissalde, G. Kenet, C. Escuriola Ettingshausen, A. Borel-Derlon, T. Lambert, G. Pasta and C. Négrier

    Version of Record online : 5 JAN 2016, DOI: 10.1111/hae.12860

  2. Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

    Haemophilia

    Volume 21, Issue 3, May 2015, Pages: 343–350, S. Kepa, B. Horvath, S. Reitter-Pfoertner, M. Schemper, P. Quehenberger, M. Grundbichler, M. Heistinger, P. Neumeister, C. Mannhalter and I. Pabinger

    Version of Record online : 13 JAN 2015, DOI: 10.1111/hae.12592

  3. You have free access to this content
    New predictive approaches for ITI treatment

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 27–43, G. D. Minno, E. Santagostino, K. Pratt and C. Königs

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12467

  4. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements

    Haemophilia

    Volume 20, Issue 4, July 2014, Pages: 550–558, M. Trossaert, A. Lienhart, C. Nougier, M. Fretigny, M. Sigaud, S. Meunier, M. Fouassier, C. Ternisien, C. Negrier and Y. Dargaud

    Version of Record online : 12 FEB 2014, DOI: 10.1111/hae.12381

  5. Activation, activity and inactivation of factor VIII in factor VIII products

    Haemophilia

    Volume 22, Issue 3, May 2016, Pages: 462–473, T. Orfeo, R. Elsman, M. Gissel, K. G. Mann and S. Butenas

    Version of Record online : 29 JAN 2016, DOI: 10.1111/hae.12872

  6. You have full text access to this OnlineOpen article
    Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors

    Haemophilia

    Volume 20, Issue 6, November 2014, Pages: 905–911, M. I. Bravo, B. Da Rocha-Souto, S. Grancha and J. I. Jorquera

    Version of Record online : 25 AUG 2014, DOI: 10.1111/hae.12494

  7. You have free access to this content
    Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 2–16, P. M. Mannucci, Q. Shi, S. Bonanad and R. Klamroth

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12465

    Corrected by:

    Erratum: Erratum

    Vol. 20, Issue 5, e376, Version of Record online: 28 AUG 2014

  8. Predictive immunogenicity of Refacto®AF

    Haemophilia

    Volume 20, Issue 4, July 2014, Pages: 486–492, S. Delignat, Y. Repessé, L. Gilardin, J. D. Dimitrov, Y.C. Lone, S. V. Kaveri and S. Lacroix-Desmazes

    Version of Record online : 30 DEC 2013, DOI: 10.1111/hae.12348

  9. Desmopressin in haemophilia: The need for a standardised clinical response and individualised test regimen

    Haemophilia

    S. C. M. Stoof, L. M. Schütte, F. W. G. Leebeek, M. H. Cnossen and M. J. H. A. Kruip

    Version of Record online : 21 JUN 2017, DOI: 10.1111/hae.13295

  10. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics

    Haemophilia

    Volume 23, Issue 2, March 2017, Pages: 292–299, J. Kahle, A. Orlowski, D. Stichel, J. F. Healey, E. T. Parker, S. M. Donfield, J. Astermark, E. Berntorp, P. Lollar, D. Schwabe and C. Königs

    Version of Record online : 8 NOV 2016, DOI: 10.1111/hae.13105

  11. Non-genetic risk factors in haemophilia A inhibitor management – the danger theory and the use of animal models

    Haemophilia

    Volume 22, Issue 5, September 2016, Pages: 657–666, K. M. Lövgren, H. Søndergaard, S. Skov and B. Wiinberg

    Version of Record online : 26 AUG 2016, DOI: 10.1111/hae.13075

  12. Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency

    Haemophilia

    Volume 21, Issue 3, May 2015, Pages: e202–e209, O. Roualdes, C. Nougier, M. Fretigny, E. Talagrand, B. Durand, C. Negrier and C. Vinciguerra

    Version of Record online : 24 FEB 2015, DOI: 10.1111/hae.12651

  13. Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII

    Haemophilia

    Volume 22, Issue 5, September 2016, Pages: 806–812, S. Kitchen, I. Jennings, M. Makris, D. P. Kitchen, T. A. L. Woods and I. D. Walker

    Version of Record online : 24 MAY 2016, DOI: 10.1111/hae.12962

  14. von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivo

    Haemophilia

    Volume 19, Issue 4, July 2013, Pages: 539–545, L. Tang, L. Leong, D. Sim, E. Ho, J.-M. Gu, D. Schneider, R. I. Feldman, F. Monteclaro, H. Jiang and J. E. Murphy

    Version of Record online : 28 MAR 2013, DOI: 10.1111/hae.12116

  15. Product-dependent anti-factor VIII antibodies

    Haemophilia

    Volume 19, Issue 4, July 2013, Pages: 619–625, S. Butenas, J. Krudysz-Amblo, G. E. Rivard and K. G Mann

    Version of Record online : 4 APR 2013, DOI: 10.1111/hae.12127

  16. Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey

    Haemophilia

    Volume 22, Issue 5, September 2016, Pages: 739–751, J. Windyga, G. Dolan, C. Altisent, O. Katsarou, M.-F. López Fernández, B. Zülfikar and on behalf of the EHTSB

    Version of Record online : 13 JUN 2016, DOI: 10.1111/hae.12955

  17. You have free access to this content
    Inhibitors – genetic and environmental factors

    Haemophilia

    Volume 20, Issue s4, May 2014, Pages: 87–93, D. Lillicrap, K. Fijnvandraat and E. Santagostino

    Version of Record online : 25 APR 2014, DOI: 10.1111/hae.12412

  18. Optimization of the thrombin generation test components to measure potency of factor VIII concentrates

    Haemophilia

    Volume 22, Issue 5, September 2016, Pages: 780–789, N. K. Jha, S. A. Shestopal, M. J. Gourley, S. A. Woodle, Y. Liang, A. G. Sarafanov, M. Weinstein and M. V. Ovanesov

    Version of Record online : 1 APR 2016, DOI: 10.1111/hae.12943

  19. The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studies in vitro

    Haemophilia

    Volume 18, Issue 6, November 2012, Pages: 917–925, F. A. Ofosu, H. Tse, A. Naqvi, H. Bhakta and Y. Song

    Version of Record online : 3 JUN 2012, DOI: 10.1111/j.1365-2516.2012.02861.x

  20. US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors

    Haemophilia

    Volume 21, Issue 5, September 2015, Pages: 559–567, L. A. Valentino, C. L. Kempton, R. Kruse-Jarres, P. Mathew, S. L. Meeks, U. M. Reiss and on behalf of the International Immune Tolerance Induction Study Investigators

    Version of Record online : 2 JUN 2015, DOI: 10.1111/hae.12730